Biorem Reports Record Quarterly Revenues and Earnings, - $14.9 Million of Revenues in the Quarter and Quarterly EPS of $0.14

GUELPH, ON, Nov. 6, 2024 /CNW/ - BIOREM Inc. (TSXV:BRM) ("BIOREM" or "The Company") today announced its results for the three and nine-month periods ended September 30, 2024. BIOREM's complete third quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

FINANCIAL HIGHLIGHTS:

 in Canadian dollars, '000's except earnings per share

Three-months ended

Nine-months ended

September 30

September 30

2024

2023

2024

2023

Revenue

14,886

5,509

28,104

12,959

Gross profit

5,021

1,544

8,458

2,615

Operating expenses

1,992